SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001567619-15-001328
Filing Date
2015-10-06
Accepted
2015-10-06 16:28:56
Documents
4
Period of Report
2015-10-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s000911x12-8k.htm 8-K 21197
2 EXHIBIT 3.1 s000911x12_ex3-1.htm EX-3.1 38712
3 EXHIIT 3.2 s000911x12_ex3-2.htm EX-3.2 122532
4 EXHIBIT 99.1 s000911x12_ex99-1.htm EX-99.1 5986
  Complete submission text file 0001567619-15-001328.txt   189635
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 151146360
SIC: 2834 Pharmaceutical Preparations